KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Abbott Laboratories (ABT) Change in Acquisitions & Divestments (2017)

Abbott Laboratories' Change in Acquisitions & Divestments history spans 1 years, with the latest figure at -$1.8 billion for Q4 2017.

On a quarterly basis, Change in Acquisitions & Divestments changed N/A to -$1.8 billion in Q4 2017 year-over-year; TTM through Dec 2017 was $129.0 million, a N/A change, with the full-year FY2025 number at $3.0 million, down 89.29% from a year prior.
Change in Acquisitions & Divestments hit -$1.8 billion in Q4 2017 for Abbott Laboratories, down from $53.0 million in the prior quarter.
Over the last five years, Change in Acquisitions & Divestments for ABT hit a ceiling of $1.7 billion in Q1 2017 and a floor of -$1.8 billion in Q4 2017.